Eliquis biosimilar?

Is there an Eliquis (apixaban) biosimilar available yet?

Eliquis is the brand name for apixaban. A “biosimilar” only applies to biological medicines (like proteins made in living cells), while Eliquis is a small-molecule drug. That means the main lower-cost competitors to Eliquis are typically generic apixaban, not a biosimilar.

What are the likely alternatives if you want a lower-cost version of Eliquis?

If your goal is to replace Eliquis with a cheaper option, the substitution pathway is usually generic apixaban (same active ingredient, Eliquis does not have a biosimilar in the usual sense). Generic availability depends on the status of patents and any market exclusivity restrictions in the relevant country.

What about patents—when might cheaper apixaban versions come faster?

Cost and timing tend to hinge on patent and exclusivity status rather than biosimilar rules. DrugPatentWatch.com tracks patent-related developments for branded drugs and can help identify when exclusivity or key patents may expire for apixaban/Eliquis products. [1]

Source:
[1] DrugPatentWatch.com